- $115.66m
- $107.98m
- $44.86m
Brief: Augmedix Inc Enters Fourth Omnibus Amendment With Dignity Health And Other Parties
Brief: Augmedix & Augmedix Opco Entered Amendment That Extends Maturity Date Of Revolving Credit Facility
Brief: Augmedix Extends Term Loan Facility And Finalizes Terms For Equity Line Of Credit
Brief: Augmedix Inc Files For Offering Of Up To 9.4 Million Shares Of Common Stock By Selling Securityholders- SEC Filing
Augmedix rises on Q1 revenue beat
Brief: Augmedix Delivers Continued Sales Momentum, Reports Q1 2023 Results
Augmedix jumps after raising $12 mln from HCA Healthcare, Redmile Group
Augmedix up after raising $12 mln from HCA and Redmile Group
Brief: Augmedix Announces Partnership With HCA Healthcare To Accelerate The Development Of AI-Enabled Ambient Documentation
Brief: Augmedix Secures Strategic Financing From HCA Healthcare And Redmile Group
Augmedix Inc reports results for the quarter ended in December - Earnings Summary
Brief: Augmedix Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: Augmedix Generates Strong Bookings In Q4, Expects Revenue To Of $8.5 Mln To $8.6 Mln
Brief: Augmedix Inc On December 20, 2022, Delivered Written Notice To Jefferies Llc To Terminate Sales Agreement Effective As Of December 20, 2022
Brief: Augmedix Reports Third Quarter 2022 Financial Results
Brief: Augmedix Announces Expanded Partnership With Adventist Health
Brief: Augmedix Q2 Revenue Up 42% To $7.3 Mln
Brief: Augmedix Inc Files Prospectus Related To 29.1 Million Shares Of Common Stock
Brief: Augmedix Inc - Entered Into An Open Market Sale Agreement Relating To Sale Of Shares Of Up To $25 Million